• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

唐氏综合征相关急性巨核细胞白血病中患者特异性GATA1突变体与RUNX1的物理关联。

Physical association of the patient-specific GATA1 mutants with RUNX1 in acute megakaryoblastic leukemia accompanying Down syndrome.

作者信息

Xu G, Kanezaki R, Toki T, Watanabe S, Takahashi Y, Terui K, Kitabayashi I, Ito E

机构信息

1Department of Pediatrics, Hirosaki University School of Medicine, Hirosaki, Japan.

出版信息

Leukemia. 2006 Jun;20(6):1002-8. doi: 10.1038/sj.leu.2404223.

DOI:10.1038/sj.leu.2404223
PMID:16628190
Abstract

Mutations of the GATA1 gene on chromosome X have been found in almost all cases of transient myeloproliferative disorder and acute megakaryoblastic leukemia (AMKL) accompanying Down syndrome (DS). Although most GATA1 mutations lead to the expression of GATA1s lacking the N-terminal activation domain, we recently found two novel GATA1 proteins with defects in another N-terminal region. It has been suggested that loss of the N-terminal portion of GATA1 might interfere with physiological interactions with the critical megakaryocytic transcription factor RUNX1, and this would imply that GATA1s is not able to interact properly with RUNX1. However, the interaction domain of GATA1 remains controversial. In this study, we show that GATA1 binds to RUNX1 through its zinc-finger domains, and that the C-finger is indispensable for synergy with RUNX1. All of the patient-specific GATA1 mutants interacted efficiently with RUNX1 and retained their ability to act synergistically with RUNX1 on the megakaryocytic GP1balpha promoter, whereas the levels of transcriptional activities were diverse among the mutants. Thus, our data indicate that physical interaction and synergy between GATA1 and RUNX1 are retained in DS-AMKL, although it is still possible that increased RUNX1 activity plays a role in the development of leukemia in DS.

摘要

在几乎所有唐氏综合征(DS)伴发的暂时性骨髓增殖性疾病和急性巨核细胞白血病(AMKL)病例中,均发现了X染色体上GATA1基因的突变。尽管大多数GATA1突变会导致缺乏N端激活域的GATA1s的表达,但我们最近发现了另外两种在另一个N端区域存在缺陷的新型GATA1蛋白。有人提出,GATA1 N端部分的缺失可能会干扰与关键巨核细胞转录因子RUNX1的生理相互作用,这意味着GATA1s无法与RUNX1正常相互作用。然而,GATA1的相互作用结构域仍存在争议。在本研究中,我们表明GATA1通过其锌指结构域与RUNX1结合,并且C指对于与RUNX1协同作用是不可或缺的。所有患者特异性的GATA1突变体均与RUNX1有效相互作用,并保留了在巨核细胞GP1balpha启动子上与RUNX1协同作用的能力,尽管突变体之间的转录活性水平各不相同。因此,我们的数据表明,GATA1与RUNX1之间的物理相互作用和协同作用在DS-AMKL中得以保留,尽管RUNX1活性增加仍有可能在DS白血病的发生中起作用。

相似文献

1
Physical association of the patient-specific GATA1 mutants with RUNX1 in acute megakaryoblastic leukemia accompanying Down syndrome.唐氏综合征相关急性巨核细胞白血病中患者特异性GATA1突变体与RUNX1的物理关联。
Leukemia. 2006 Jun;20(6):1002-8. doi: 10.1038/sj.leu.2404223.
2
Identification of distinct molecular phenotypes in acute megakaryoblastic leukemia by gene expression profiling.通过基因表达谱分析鉴定急性巨核细胞白血病中不同的分子表型。
Proc Natl Acad Sci U S A. 2006 Feb 28;103(9):3339-44. doi: 10.1073/pnas.0511150103. Epub 2006 Feb 21.
3
Acquired mutations in GATA1 in the megakaryoblastic leukemia of Down syndrome.唐氏综合征巨核母细胞白血病中GATA1的获得性突变。
Nat Genet. 2002 Sep;32(1):148-52. doi: 10.1038/ng955. Epub 2002 Aug 12.
4
GATA1 as a new target to detect minimal residual disease in both transient leukemia and megakaryoblastic leukemia of Down syndrome.GATA1作为检测唐氏综合征短暂性白血病和巨核细胞白血病微小残留病的新靶点。
Leuk Res. 2005 Nov;29(11):1353-6. doi: 10.1016/j.leukres.2005.04.007.
5
Risk for leukemia in infants without Down syndrome who have transient myeloproliferative disorder.患有短暂性骨髓增殖性疾病的非唐氏综合征婴儿患白血病的风险。
J Pediatr. 2006 May;148(5):687-9. doi: 10.1016/j.jpeds.2005.12.031.
6
GATA1 mutations in patients with down syndrome and acute megakaryoblastic leukaemia do not always confer a good prognosis.唐氏综合征和急性巨核细胞白血病患者中的GATA1突变并不总是预示着良好的预后。
Pediatr Blood Cancer. 2009 Jul;53(1):108-11. doi: 10.1002/pbc.21983.
7
A rare case of GATA1 negative chemoresistant acute megakaryocytic leukemia in an 8-month-old infant with trisomy 21.一例罕见的 GATA1 阴性化疗耐药性急性巨核细胞白血病发生于一名 8 月龄伴有 21 三体的婴儿。
Pediatr Blood Cancer. 2010 Jul 1;54(7):1048-9. doi: 10.1002/pbc.22331.
8
GATA1, cytidine deaminase, and the high cure rate of Down syndrome children with acute megakaryocytic leukemia.GATA1、胞苷脱氨酶与唐氏综合征急性巨核细胞白血病患儿的高治愈率
J Natl Cancer Inst. 2005 Feb 2;97(3):226-31. doi: 10.1093/jnci/dji026.
9
Differential gene expression, GATA1 target genes, and the chemotherapy sensitivity of Down syndrome megakaryocytic leukemia.唐氏综合征巨核细胞白血病的差异基因表达、GATA1靶基因与化疗敏感性
Blood. 2006 Feb 15;107(4):1570-81. doi: 10.1182/blood-2005-06-2219. Epub 2005 Oct 25.
10
Mutations in GATA1 in both transient myeloproliferative disorder and acute megakaryoblastic leukemia of Down syndrome.唐氏综合征短暂性骨髓增殖性疾病和急性巨核细胞白血病中GATA1基因的突变
Blood Cells Mol Dis. 2003 Nov-Dec;31(3):351-6. doi: 10.1016/j.bcmd.2003.08.001.

引用本文的文献

1
GATA1 in Normal and Pathologic Megakaryopoiesis and Platelet Development.GATA1 在正常和病态巨核细胞生成及血小板发育中的作用。
Adv Exp Med Biol. 2024;1459:261-287. doi: 10.1007/978-3-031-62731-6_12.
2
Pharmacological inhibition of RUNX1 reduces infarct size after acute myocardial infarction in rats and underlying mechanism revealed by proteomics implicates repressed cathepsin levels.蛋白组学研究揭示,通过药理学抑制 RUNX1 可减少大鼠急性心肌梗死后的梗死面积,其潜在机制与抑制组织蛋白酶水平有关。
Funct Integr Genomics. 2024 Jun 12;24(3):113. doi: 10.1007/s10142-024-01391-2.
3
Tumor cell-released kynurenine biases MEP differentiation into megakaryocytes in individuals with cancer by activating AhR-RUNX1.
肿瘤细胞释放的犬尿氨酸通过激活 AhR-RUNX1 使癌症患者的 MEP 分化为巨核细胞。
Nat Immunol. 2023 Dec;24(12):2042-2052. doi: 10.1038/s41590-023-01662-3. Epub 2023 Nov 2.
4
RUN(X) out of blood: emerging RUNX1 functions beyond hematopoiesis and links to Down syndrome.RUNX1 除了在造血方面的作用之外,还有一些新的功能,并且与唐氏综合征有关。
Hum Genomics. 2023 Sep 5;17(1):83. doi: 10.1186/s40246-023-00531-2.
5
RUNX1 isoform disequilibrium promotes the development of trisomy 21-associated myeloid leukemia.RUNX1 异构体失衡促进 21 三体相关骨髓性白血病的发展。
Blood. 2023 Mar 9;141(10):1105-1118. doi: 10.1182/blood.2022017619.
6
Pharmacologic targeting of the P-TEFb complex as a therapeutic strategy for chronic myeloid leukemia.靶向 P-TEFb 复合物的药物治疗作为慢性髓性白血病的一种治疗策略。
Cell Commun Signal. 2021 Aug 9;19(1):83. doi: 10.1186/s12964-021-00764-5.
7
Acute Megakaryocytic Leukemia.急性巨核细胞白血病。
Cold Spring Harb Perspect Med. 2020 Feb 3;10(2):a034884. doi: 10.1101/cshperspect.a034884.
8
Megakaryopoiesis and platelet production: insight into hematopoietic stem cell proliferation and differentiation.巨核细胞生成与血小板生成:对造血干细胞增殖和分化的见解
Stem Cell Investig. 2015 Feb 14;2:3. doi: 10.3978/j.issn.2306-9759.2015.02.01. eCollection 2015.
9
Impairment of hepatic nuclear factor-4α binding to the Stim1 promoter contributes to high glucose-induced upregulation of STIM1 expression in glomerular mesangial cells.肝细胞核因子-4α与Stim1启动子结合受损,导致高糖诱导肾小球系膜细胞中STIM1表达上调。
Am J Physiol Renal Physiol. 2015 May 15;308(10):F1135-45. doi: 10.1152/ajprenal.00563.2014. Epub 2015 Mar 18.
10
Global transcriptome and chromatin occupancy analysis reveal the short isoform of GATA1 is deficient for erythroid specification and gene expression.全球转录组和染色质占据分析表明,GATA1的短异构体在红细胞分化和基因表达方面存在缺陷。
Haematologica. 2015 May;100(5):575-84. doi: 10.3324/haematol.2014.112714. Epub 2015 Feb 14.